The monopolar electrosurgery instrument market is expected to register a CAGR of nearly 3.9% during the forecast period, 2021-2026. Overall, the monopolar electrosurgery instrument market may be impacted moderately due to the COVID-19 pandemic, with hospitals deferring elective surgeries and patients delaying visits due to fear of contracting the virus. Recommendations and guidelines for prioritizing surgical procedures were provided for the management of healthcare services in different countries. For instance, in March 2020, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the European Association and Endoscopic Surgery (EAES) recommended minimizing the usage of monopolar electrosurgery, ultrasonic dissectors, and advance bipolar devices due to the risk of particle aerosolization. During the same month, similar guidelines were given by the American Association of Gynecologic Laparoscopists (AAGL). With the situation returning to normal, the backlog of procedures is expected to recover.
An increasing number of minimally invasive surgical techniques are likely to be the primary driving factor for the monopolar electrosurgery instrument market. Minimally invasive surgical techniques reduce the complications in patients, reduce the period of hospital stay, reduce the rate of readmittance, and lead to cost savings. A national survey conducted in Italy showed the extensive usage of high energy devices in minimally invasive elective procedures at upper and lower GI tracts, liver, pancreas, and adrenal glands. Additionally, other factors contributing to the growth include technological advancements and an increased number of medical surgeries. According to OECD, from 2016 to 2018, laparoscopic-assisted procedures, such as appendectomy, cholecystectomy, hernia repair, and hysterectomy, increased by 9% in the United Kingdom, 27% in Spain, and 11% in Italy.
Lack of expertise in handling these devices may result in serious consequences for patients. Irrespective of specialty, there exists a knowledge gap among surgeons regarding the effective use of energy devices in surgery. Accidental punctures and lacerations due to error injuries and stray energy burns during laparoscopic procedures may discourage patients from opting for such surgeries. Another factor is the increasing number of robotic surgeries, which may limit the use of other traditional approaches due to increased accuracy and technological advancements.
Key Market Trends
The Hand Instruments Segment Accounts for a Significant Share in the Market
The COVID-19 pandemic has affected many domains of healthcare due to the delay of elective surgeries and the prioritizing of emergency-only procedures. A global expert response study published in May 2020 estimated that nearly 28 million adult elective procedures were canceled or postponed during the 12 weeks of peak disruption. Furthermore, companies were similarly affected due to imposed lockdowns and delayed distribution channels.
A handpiece is used in conjunction with the generator for the passing of electric current to the surgical site. Due to the increasing technological advancements by companies in the hand instruments segment, the handpiece occupies a majority share compared to generators, return electrodes, and accessories. In January 2021, the FDA issued 510(k) clearance of the Apyx J-Plasma handpiece, which uses cold plasma technology. Such factors may push the competition and demand innovation in this segment.
Additionally, the growing adoption of minimally invasive surgeries, such as laparoscopy, may further contribute toward the growth of this segment. According to Eurostat, in 2018, more than half of the cholecystectomy procedures used laparoscopy. For instance, nearly 93% of procedures performed in the United Kingdom were laparoscopic cholecystectomy.
North America is Expected to Dominate the Monopolar Electrosurgery Instruments Market
The United States has experienced a huge impact due to COVID-19. The country’s healthcare sector had to divert its services toward managing COVID-19 patients and vaccine development. Guiding committees and regulatory bodies released guidelines and recommendations to be followed for patients and physicians. Elective procedures had to be postponed, and only emergency procedures were given high importance. Recovery of these backlog procedures may begin slowly, considering the pandemic situation and the resurgence of the disease.
However, North America is expected to dominate the overall market compared to other regions during the forecast period. Through reference from companies’ financial statements, North America holds the leading position in sales. For Medtronic, the United States represents nearly 50% of the net sales generated under the minimally invasive therapies group. Multinational companies across the world also prefer to expand to the region due to its favorable economic conditions and scope for innovation.
Furthermore, there is a rising patient population and increasing surgical procedures being performed in the region. Surgical instruments are used in various fields, such as cardiovascular, urology, orthopedic, cosmetic, and gynecology. Around 16.3 million minimally invasive cosmetic surgical procedures were performed in 2019, according to the American Society of Plastic Surgeons (ASPS). The growth in the number of surgical procedures performed may help North America maintain its position in the overall market.
The monopolar electrosurgical instruments market remains highly competitive in nature, with several key players dominating the market. Innovations, product launches, and strategic alliances are likely to open new opportunities for growth in the market. Some of the major players include CONMED Corporation, Olympus Corporation, Medtronic PLC, Apyx Medical Corporation, Johnson & Johnson, Erbe Elektromedizin GmbH, BOWA MEDICAL, KLS Martin Group, Aesculap Inc., Meyer-Haake GmbH Medical Innovations, Encision Inc., and Stryker Corporation.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Increased Adoption of Minimally Invasive Techniques
4.2.2 Growing Number of Medical, Cosemtic, and Age-related Surgeries
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Lack of Knowledge Regarding Safe Usage
4.3.2 Rise in Use of Robotic Surgeries
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Hand Instruments
5.1.2 Surgical Generator
5.1.3 Return Electrode
5.2 By End User
5.2.2 Ambulatory Surgical Centers
5.2.3 Other End Users
5.3 By Application
5.3.1 General Surgery
5.3.2 Gynecological Surgery
5.3.3 Cardiovascular Surgery
5.3.4 Orthopedic Surgery
5.3.5 Cosmetic Surgery
5.3.6 Other Surgeries
5.4.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle-East and Africa
5.4.5 South America
188.8.131.52 Rest of South America
6.1.1 CONMED Corporation
6.1.2 Olympus Corporation
6.1.3 Medtronic PLC
6.1.4 Apyx Medical Corporation
6.1.5 Johnson & Johnson
6.1.6 Erbe Elektromedizin GmbH
6.1.7 BOWA MEDICAL
6.1.8 KLS Martin Group
6.1.9 Aesculap Inc.
6.1.10 Meyer-Haake GmbH Medical Innovations
6.1.11 Encision Inc.
6.1.12 Stryker Corporation